Dehydroepiandrosterone and dehydroepiandrosterone sulfate: Anabolic, neuroprotective, and neuroexcitatory properties in military men

Military Medicine

Volumn 178, Issue 1, 2013, Pages 100-106

  Taylor, Marcus K ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; HYDROCORTISONE; NERVE GROWTH FACTOR; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; ARTICLE; CHEMISTRY; CROSS-SECTIONAL STUDY; ENZYME IMMUNOASSAY; HUMAN; MALE; REGRESSION ANALYSIS; SALIVA; SOLDIER;

ADULT; ALPHA-AMYLASES; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; HUMANS; HYDROCORTISONE; IMMUNOENZYME TECHNIQUES; MALE; MILITARY PERSONNEL; NERVE GROWTH FACTOR; REGRESSION ANALYSIS; SALIVA; TESTOSTERONE;

MLCS; MLOWN;

EID: 84875001534     PISSN: 00264075     EISSN: 1930613X     Source Type: Journal    
DOI: 10.7205/MILMED-D-12-00296     Document Type: Article

References (33)

1. Baulieu EE, Robel P: Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci 1998; 95: 4089-91.
2. Miller WL: Molecular biology of steroid hormone synthesis. Endocr Rev 1988; 9: 295-318.
3. Payne AH, Hales DB: Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 2004; 25(6): 947-70.
4. Kimonides VG, Spillantini MG, Sofroniew MV, Fawcett JW, Herbert J: Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience 1999; 89: 429-36.
5. Tanaka M, Sokabe M: Continuous de novo synthesis of neurosteroids is required for normal synaptic transmission and plasticity in the dentate gyrus of the rat hippocampus. Neuropharmacology 2012; 62: 2373-87.
6. Lazaridis I, Charalampopoulos I, Alexaki VI, et al: Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis. PLoS Biol 2011; 9(4): e1001051.
7. HulinMW, Amato RJ, Porter JR, FilipeanuCM, Winsauer PJ:Neurosteroid binding sites on the GABA(A) receptor complex as novel targets for therapeutics to reduce alcohol abuse and dependence [published online ahead of print October 31, 2011]. Adv Pharmacol Sci. doi: 10.1155/2011/926361.
8. Xu Y, Tanaka M, Chen L, Sokabe M: DHEAS induces short-term potentiation via the activation of metabotropic glutamate receptor in the rat hippocampus. Hippocampus 2012; 22: 707-22.
9. Bastianetto S, Ramassamy C, Poirier J, Quiron R: Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 1999; 66: 35-41.
10. Compagnone NA, Mellon SH: Dehydroepiandrosterone: a potential signaling molecule for neurocortical organization during development. Proc Natl Acad Sci 1998; 95: 4678-83.
11. Karishma KK, Herbert J: Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone induced suppression. Eur J Neurosci 2002; 16: 445-53.
12. Gartside SE, Griffith NC, Kaura V, Ingram CD: The neurosteroid dehydroepiandrosterone (DHEA) and its metabolites alter 5-HT neuronal activity via modulation of GABAA receptors. J Psychopharmacol 2010; 24(11): 1717-24.
13. Moriguchi 2011 Yamamoto Y, Ikuno T, Fukunaga K: Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice. J Neurochem 2011; 117(5): 879-91.
14. Gubba EM Fawcett JW, Herbert J: The effects of corticosterone and dehydroepiandrosterone on neurotrophic factor mRNA expression in primary hippocampal and astrocyte cultures. Brain Res Mol Brain Res 2004; 127(1-2): 48-59.
15. Newman AE, MacDougall-Shackleton SA, An YS, Kriengwatana B, Soma KK: Corticosterone and dehydroepiandrosterone have opposing effects on adult neuroplasticity in the avian song control system. J Comp Neurol 2010; 518(18): 3662-78.
16. Schulte-Herbrüggen O, Litzke J, Hornych K, et al: Maternal nerve growth factor serum levels in the perinatal period. J Reprod Immunol 2007; 74(1-2): 170-3.
17. Dazzi L, Matzeu A, Biggio G: Role of ionotropic glutamate receptors in the regulation of hippocampal norepinephrine output in vivo. Brain Res 2011; 1386: 41-9.
18. Giordano R, Grottoli S, Brossa P, et al: Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans. Clin Endocrinol 2003; 59(3): 314-20.
19. Imamura M, Prasad C: Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem Biophys Res Commun 1998; 243(3): 771-5.
20. Park-Chung M, Malayev A, Purdy RH, Gibbs TT, Farb DH: Sulfated and unsulfated steroids modulate gamma-aminobutyric acid A receptor function through distinct sites. Brain Res 1999; 830(1): 72-87.
21. Morgan CA III, Rasmusson A, Pietrzak RH, Coric V, Southwick SM: Relationships among plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate, cortisol, symptoms of dissociation, and objective performance in humans exposed to underwater navigation stress. Biol Psychiatry 2009; 66: 334-40.
22. Taylor MK, Padilla GA, Stanfill KE, et al: Effects of dehydroepiandrosterone supplementation during stressful military training: a randomized, controlled, double-blind field study. Stress 2012; 15(1): 85-96.
23. Hoffman SW, Virmani S, Simkins RM, Stein DG: The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats. J Neurotrauma 2003; 20(9): 859-70.
24. Malik AS, Narayan RK, Wendling WW, et al: A novel dehydroepiandrosterone analog improves functional recovery in a rat traumatic brain injury model. J Neurotrauma 2003; 20(5): 463-76.
25. Granger DA, Kivlighan KT, Fortunato C, et al: Integration of salivary biomarkers into developmental and behaviorally-oriented research: problems and solutions for collecting specimens. Physiol Behav 2007; 92(4): 583-90.
26. Nater UM, Rohleder N, Schlotz W, Ehlert U, Kirschbaum C: Determinants of the diurnal course of salivary alpha-amylase. Psychoneuroendocrinology 2007; 32: 392-401.
27. Nater UM, La Marca R, Florin L, et al: Stress-induced changes in human salivary alpha-amylase activity-associations with adrenergic activity. Psychoneuroendocrinology 2006; 31(1): 49-58.
28. Van Stegeren A, Rohleder N, Everaerd W, Wolf OT: Salivary alpha amylase as marker for adrenergic activity during stress: effect of betablockade. Psychoneuroendocrinology 2006; 31(1): 137-41.
29. Stuart-Hamilton I: Dictionary of Psychological Testing, Assessment and Treatment. Philadelphia, Jessica Kingsley Publishers, 2007.
30. Steiner PM, Cook TD, Shadish WR, Clark MH: The importance of covariate selection in controlling for selection bias in observational studies. Psychol Methods 2010; 15(3): 250-67.
31. Smith KS, Rudolph U: Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABAA receptor subtypes. Neuropharmacology 2012; 62(1): 54-62.
32. Charney DS: Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry 2004; 161(2): 195-216.
33. Hu Y, Cardounel A, Gursoy E, Anderson P, Kalimi M: Anti-stress effects of dehydroepiandrosterone: protection of rats against repeated immobilization stress-induced weight loss, glucocorticoid receptor production, and lipid peroxidation. Biochem Pharmacol 2000; 59(7): 753-62.